FdaApplication

ANDA 208784

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA
application_typeANDA
approval_date2017-09-21

Products (2)

ProductActive ingredientStrengthDosage form
LANSOPRAZOLELANSOPRAZOLE15MGTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
LANSOPRAZOLELANSOPRAZOLE30MGTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

2 products